Navigation Links
Cogent Systems and Northrop Grumman Reach Agreement to Settle Automated Fingerprint Identification Technology Suit and Create Strategic Alliance
Date:9/22/2007

LOS ANGELES, Sept. 10 /PRNewswire-FirstCall/ -- Cogent Systems (Nasdaq: COGT) and Northrop Grumman Corporation (NYSE: NOC) today announced that they have reached an agreement to settle Cogent's lawsuit against Northrop Grumman regarding Cogent's automated fingerprint identification technology. The agreement is subject to negotiation and execution of definitive documents.

Under the terms of the agreement, Northrop Grumman has agreed to pay Cogent $25 million to settle the litigation. Northrop Grumman also has agreed to pay Cogent $15 million for a non-exclusive license to use specified Cogent state-of-the-art automated fingerprint identification software in certain existing programs, including IDENT1. Northrop Grumman and Cogent also have agreed to enter into a five-year research and development, service and products agreement, under which Northrop Grumman will pay Cogent $20 million for products and services over the term of the agreement. Northrop Grumman does not expect the terms of the settlement to have an impact on its guidance for 2007.

This settlement will end the litigation and allow the companies to work together as strategic alliance partners to provide future customers with state-of-the-art fingerprint identification technology and other biometric solutions.

Cogent filed suit in 2005 alleging that Northrop Grumman had misappropriated its proprietary technology and trade secrets for automated fingerprint identification software for use on the IDENT 1 contract with the British Police Information Technology Organisation, and its successor the National Policing Improvement Agency.

Northrop Grumman Corporation is a $30 billion global defense and technology company whose 120,000 employees provide innovative systems, products, and solutions in information and services, electronics, aerospace and shipbuilding to government and commercial customers worldwide.

Cogent is a global biometric identification solutions provider to governments, law enforcement agencies, and commercial enterprises. Cogent provides the highest quality identification systems, products and services with leading technology, accuracy and speed. Cogent's Automated Fingerprint/Palmprint Identification Systems, or AFIS, enable customers to capture fingerprint and palm print images electronically, encode prints into searchable files, and accurately compare a set of fingerprints/palm prints to a database containing potentially millions of prints in seconds.

Forward-Looking Statements

This press release contains, in addition to historical information, forward-looking statements. Such statements are based on management's current estimates and expectations and are subject to a number of uncertainties and risks that could cause actual results to differ materially from those described in the forward-looking statements. Cogent and Northrop Grumman are

providing this information as of the date of this press release, and expressly disclaim any duty to update information contained in this press release.

Forward-looking statements in this press release include, without limitation, express and implied statements regarding the timing and terms of the definitive documents related to the settlement, potential revenue that may be received by Cogent under the proposed settlement documents and the potential benefits of the anticipated business relationship between Cogent and Northrop Grumman. These forward-looking statements involve risks and uncertainties which could cause actual results to differ materially from those expressed or implied here. Readers are referred to Cogent's Report on Form 10- Q for the quarter ended June 30, 2007 filed by Cogent with the Securities and Exchange Commission which identifies important risk factors that could cause actual results to differ from those contained in the forward-looking statements, including but not limited to: the risk that negotiations over the definitive documents may result in the inclusion of provisions that modify the anticipated timing or benefits currently anticipated; and risks that issues not currently anticipated will delay, modify or impair the completion of the settlement. The information contained in this press release is a statement of Cogent's and Northrop Grumman's present intention, belief or expectation and is based upon, among other things, existing industry conditions, market conditions, the economy in general and Cogent's and Northrop Grumman's assumptions. Either Cogent or Northrop Grumman may change its intention, belief or expectation, at any time and without notice, based upon any changes in such factors, in its assumptions or otherwise. Neither Cogent nor Northrop Grumman undertakes any obligation to review or confirm analysts' expectations or estimates or to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. By including any information in this press release, neither Cogent nor Northrop Grumman necessarily acknowledges that disclosure of such information is required by applicable law or that the information is material.


'/>"/>
SOURCE Northrop Grumman Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology news :

1. Open microfluidic and nanofluidic systems
2. Applied Biosystems Introduces Advanced Gene Expression Service Provider Program
3. Institute for Systems Biology Symposium Addresses Need for Better Computational Tools
4. Scientists Propose Sweeping Changes to Naming of Bird Neurosystems to Acknowledge Their True Brainpower
5. Different microarray systems more alike than previously thought
6. Integration of Agilents MS technology, Proteome Systems software to help scientists in proteomics research
7. Changing ecosystems throw scientists mega-challenges
8. Scripps scientists find potential for catastrophic shifts in Pacific ecosystems
9. A new way to share models of biological systems
10. Motor transport in bio-nano systems
11. Invitrogen Launches i-Path -- A Unique Systems Biology Platform at BIO 2005
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... India , January 19, 2017 According to a ... Opportunities and Forecast, 2014 - 2022," the global biometric sensor market is expected ... 2016 to 2022. In 2015, Asia-Pacific dominated the global ... and private sectors. Continue Reading ... ...
(Date:1/13/2017)... 2017 Sandata Technologies, LLC, a leading ... industry, including Electronic Visit Verification™ (EVV™), announced today ... as Senior Vice President of Product Management. ... homecare experience to Sandata, where he will be ... align Sandata,s suite of solutions with the needs ...
(Date:1/11/2017)... Iowa , Jan. 11, 2017 Intoxalock, ... first with the release of its patent-pending calibration device. ... and reliably perform calibrations, securely upload data logs and ... for the customer. "Fighting drunk driving through ... for the public at large, but also for the ...
Breaking Biology News(10 mins):
(Date:1/24/2017)... 2017   Instrument Business Outlook ( ... MN ) the 2016 Company of the ... newsletter tracking developments in the analytical and life ... consistently achieved outstanding technical, operational and financial results ... of IBO. "In 2016, Bio-Techne capitalized on opportunities ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... company announces significant growth last year adding 65 new US and international facilities ... Army medical centers as well as one of US largest imaging center chains. ...
(Date:1/23/2017)... 23, 2017 /PRNewswire/ - Resverlogix Corp. ("Resverlogix" or the ... New Zealand based Phase 1 ... showed remarkable results in reducing inflamed protein biomarkers in ... It is believed that this is the first time ... type can be made between epigenetic regulation and its ...
(Date:1/23/2017)... Calif. , Jan. 23, 2017  Alkahest ... innovative treatments for neurodegenerative diseases and other age-related ... joined the company as Chief Medical Officer. In ... and clinical development activities at Alkahest and serve ... Jackson most recently served as Executive Director at ...
Breaking Biology Technology: